One mechanism by which myeloid cells contribute to the inhibition of anti-tumor responses is the expression of the membrane-bound ectonucleotidases CD39 and CD73, which catalyze the production of the immunosuppressive metabolite adenosine (165, 166) (Figure 4A). This evidence concerns the gene NT5E and neoplasm.